14022 ATTUNE Cementless RP Clinical Performance Evaluation

NAActive, not recruitingINTERVENTIONAL
Enrollment

540

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2027

Conditions
Osteoarthritis
Interventions
DEVICE

Cementless Total Knee Arthroplasty

Patients will undergo a primary total knee replacement using one of the two configurations of the ATTUNE Cementless knee (CR RP or PS RP)

Trial Locations (20)

4910

Krankenhaus der Barmherzigen Schwestern Ried im Innkreis, Ried im Innkreis

8083

University of Otago, Christchurch

11203

SUNY downstate Medical Center, Brooklyn

23606

Hampton Roads Orthopaedics and Sports Medicine, Newport News

27599

UNC Chapel Hill, Chapel Hill

29285

CHU de la Cavale Blanche, Brest

32720

Florida Research Associates, DeLand

37660

Associated Orthopaedics of Kingsport, Kingsport

49416

Texas Tech University Heath Science Center, Lubbock

80210

Colorado Joint Replacement, Denver

80480

Sevice de Chirurgie Orthoedique et Traumatologique, Salouël

82467

Klinikum Garmisch-Partenkirchen GmbH, Garmisch-Partenkirchen

03756

Dartmouth-Hitchcock Medical Center, Lebanon

03257

New London Hospital, New London

08234

Rothman Institute, Egg Harbor

T2N 2T9

Foothills Medical Centre, University of Calgary, Calgary

T12 X23H

South Infirmary Victoria University Hospital, Cork

5707 HA

Elkerliek Ziekenhuis, Helmond

WN6 9EP

Wrightington Hospital, Wigan

NG5 1PB

Nottingham University Hospitals NHS Trust, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

DePuy Orthopaedics

INDUSTRY

NCT02839850 - 14022 ATTUNE Cementless RP Clinical Performance Evaluation | Biotech Hunter | Biotech Hunter